HE4, also known as the whey acidic protein (WFDC2), is slightly less sensitive to the detection of early-stage ovarian cancer compared to CA-125 but it has better selectivity for distinguishing between malignant and benign pelvic masses. The gene discussed is WFDC2; the disease is ovarian carcinoma.